Pseudoagglutination

Abstract

BRMSH 541 tives, usually poor palliatives at that, and in these circumstances any dosage carrying a 16% mortality rate is far too high. During 1959-61 1 treated well over a hundred cases with " thiotepa." Roughly one-third were given the high dosage (along with testosterone propionate) recommended by Whyte Watson and Turner,' the remainder receiving about half this dosage. This experience convinced me that maximal doses do more harm than good. Dr. Basil A. Stoll is right in stressing the harmful effects of injudicious chemotherapy.2 He writes of the " dangers of piling misery upon misery in the late cancer case."-I am, etc.,